Safety assessment of a calcium-potassium salt of (-)-hydroxycitric acid

Toxicology Mechanisms and Methods

Volumn 20, Issue 9, 2010, Pages 515-525

  Stohs, Sidney J ^a   Lau, Francis C ^b   Kim, Doun ^c   Kim, Seung Un ^c   Bagchi, Manashi ^b   Bagchi, Debasis ^b,d  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b InterHealth Nutraceuticals Inc   (United States)

^c SK N Techno Park ^*  (South Korea)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

Garcinia cambogia; Hydroxycitric acid; Safety; Toxicity

Indexed keywords

CALCIUM SALT; GARCINIA CAMBOGIA EXTRACT; HYDROXYCITRIC ACID; POTASSIUM SALT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE IRRITATION; FEMALE; FETUS WEIGHT; FLUID INTAKE; FOOD INTAKE; GENOTOXICITY; HUMAN; LIPOGENESIS; MALE; NONHUMAN; OBESITY; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; REPRODUCTIVE TOXICITY; REVIEW; SINGLE DRUG DOSE; SKIN TOXICITY; TERATOGENICITY; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; CITRATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION; HUMANS; LIVER; MALE; MUTAGENS; PROTEIN KINASE INHIBITORS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RISK ASSESSMENT; SALMONELLA TYPHIMURIUM; TOXICITY TESTS;

ANIMALIA; GARCINIA; GARCINIA CAMBOGIA;

EID: 77958551643     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2010.521207     Document Type: Review

References (55)

1. Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J. 2006. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-medi-ated repression of leukocyte adhesion. Circ Res 98:490-498. (Pubitemid 43755307)
2. Boll PM, Sorensen E, Balieu E. 1969. Naturally occurring lactones and lactames. The absolute confguration of the hydroxycitric acid lactone: Hibiscus acid and Garcinia acid. Acta Chem Scand 23:286-293.
3. Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN. 2006. Histone deacety-lase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126:321-334. (Pubitemid 44092958)
4. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM. 2001. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113-1121. (Pubitemid 32995369)
5. Dannewitz B, Edrich C, Tomakidi P, Kohl A, Gabbert O, Eickholz P, Steinberg T. 2006. Elevated gene expression of MMP-1, MMP-10, and TIMP-1 reveal changes of molecules involved in turn-over of extracellular matrix in cyclosporine-induced gingival overgrowth. Cell Tis Res 325:513-522. (Pubitemid 44126166)
6. Dara L, Hewett J, Lim JK. 2008. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 14:6999-7004.
7. Deshmukh NS, Bagchi M, Yasmin T, Bagchi D. 2008a. Safety of a novel calcium/ potassium saltof (-)-hydroxycitric acid (HCA-SX): II. Developmental toxic-ity study in rats. Toxicol Mech Met 18:443-451. (Pubitemid 351883374)
8. Deshmukh NS, Bagchi M, Yasmin T, Bagchi D. 2008b. Safety of a novel calcium/ potassium salt of hydroxycitric acid (HCA-SX): I. Two-generation reproduction toxicity study. Toxicol Mech Met 18:433-442. (Pubitemid 351883375)
9. Downs BW, Bagchi M, Subbaraju G V, Shara MA, Preuss HG, Bagchi D. 2005. Bioefcacy of a novel calcium-potassium salt of (-)-hydroxycitric acid. Mutat Res 579:149-162. (Pubitemid 41540139)
10. FDA-US Food and Drug Administration. Generally Recognized as Safe (GRAS). Available online at: http://www.fda.gov/Food/FoodIngredientsPackaging/ GenerallyRecognizedasSafeGRAS/default.htm, accessed July 2010.
11. Figueroa J, Vijayagopal P, Debata C, Prasad A, Prasad C. 1999. Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice. Life Sci 64:1339-1347. (Pubitemid 29156862)
12. Friedman JM. 1998. Leptin, leptin receptors, and the control of body weight. Nut Rev 56:38-46.
13. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395:763-770. (Pubitemid 28485436)
14. Fuller RW, Wong DT, Robertson DW. 1991. Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev 11:17-34.
15. Garcia A, Sekowski A, Subramanian V, Brasaemle DL. 2003. The central domain is required to target and anchor perilipin A to lipid droplets. J Biol Chem 278:625-635. (Pubitemid 36043616)
16. Gloerich J, Ruiter JP, van den Brink DM, Ofman R, Ferdinandusse S, Wanders RJ. 2006. Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation. FEBS Lett 580:2092-2096.
17. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. 1999. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21:424-428. (Pubitemid 29159582)
18. Jones FJ, Andrews AH. 2007. Acute liver injury associated with the herbal supplement Hydroxycut in a soldier deployed in Iraq. Am J Gastroenterol 102:2357.
19. Kim BW, Choo HJ, Lee JW, Kim JH, Ko YG. 2004. Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp Mol Med 36:476-485. (Pubitemid 39556424)
20. Lau FC, Bagchi M, Sen C, Roy S, Bagchi D. 2008. Nutrigenomic analysis of diet-gene interactions on functional supplements for weight management. Curr Genomics 9:239-251. (Pubitemid 351864250)
21. Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW, Hammock BD, Couper DJ, Heiss G, Zeldin DC. 2006. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet 15:1640-1649. (Pubitemid 43904830)
22. Lijnen, H.R., Van, H.B., Frederix, L., Rio, M.C., Collen, D. 2002. Adipocyte hypertrophy in stromelysin-3 defcient mice with nutritionally induced obesity. Tromb Haemost. 87: 530-535. (Pubitemid 34232497)
23. Lin J, Handschin C, Spiegelman BM. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361-370. (Pubitemid 43960626)
24. Lingjaerde O, Kildemo O. 1981. Dopamine uptake in platelets: two diferent low afnity, saturable mechanisms. Agents Actions 11:410-416. (Pubitemid 11016829)
25. Loe YC, Bergeron N, Rodriguez N, Schwarz JM. 2001. Gas chromatography/ mass spectrometry method to quantify blood hydroxycitrate concentration. Analyt Biochem 292:148-154. (Pubitemid 32417733)
26. Lobb A. 2009. Hepatotoxicity associated with weight-loss supplements: a case for better post-marketing surveillance. World J Gastroenterol 15:1786-1787.
27. Martin FW, Campbell CW, Rubertbe RM. 1987. Perennial edible fruits of the tropics: an inventory. USDA no. 642 1-125.
28. Maquoi E, Demeulemeester D, Voros G, Collen D, Lijnen HR. 2003. Enhanced nutritionally induced adipose tissue development in mice with strome-lysin-1 gene inactivation. Tromb Haemost 89:696-704. (Pubitemid 36456967)
29. Monjok EM, Kullkarni K, Mgbere O, Kouamou G, Ohia SE, Bagchi D, Bagchi M, Opere C. 2005. Regulation of rat brain neuropeptide Y concentration by hydroxycitric acid, in vitro. FASEB 19:Abtract. 310.8.
30. Mozersky DO, Klonz K, Katz LM. 2009. The problem: liver toxicity following consumption of dietary supplement, Hydroxycut. Health Hazard Review Board FDA 2009. Available online at: www.fda.gov/oc/opacom/hottopics/ hydroxycut/HHE.pdf, accessed
31. Obunike JC, Sivaram P, Paka L, Low MG, Goldberg IJ. 1996. Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways. J Lipid Res 37:2439-2449. (Pubitemid 26427457)
32. Ohia SE, Awe O, LeDay AM, Opere CA, Bagchi D. 2001. Efect of hydroxycitric acid on serotonin release from isolated rat brain cortex. Res Commun Mol Pathol Pharmacol 109:210-216. (Pubitemid 33095144)
33. Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ. 2002. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem 238:89-103. (Pubitemid 35023532)
34. Preuss HG, Bagchi D, Bagchi M, Rao C V, Dey DK, Satyanarayana S. 2004b. Efects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabet Obes Metabol 6:171-180. (Pubitemid 38559696)
35. Preuss HG, Bagchi D, Bagchi M, Rao CVS, Satyanarayana S, Dey DK. 2004c. Efcacy of a novel, natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX, niacin bound chromium and Gymnema sylvestre extract in weight management in human volunteers: a pilot study. Nutr Res24:45. (Pubitemid 38121537)
36. Preuss HG, Garis RI, Bramble JD, Bagchi D, Bagchi M, Rao C V, Satyanarayana S. 2005. Efcacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Int J Clin Pharmacol Res 25:133-144. (Pubitemid 41719437)
37. Preuss HG, Rao C V, Garis R. 2004a. An overview of the safety and efcacy of a novel, natural (-)-hydroxycitric acid extract (HCA-SX) for weight management. J Med 35:33-48. (Pubitemid 47578939)
38. Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, Enayetallah AE, Zeldin DC, Grant DF. 2003. Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64: 482-490. (Pubitemid 36910013)
39. Roy S, Rink C, Khanna S, Phillips C, Bagchi D, Bagchi M, Sen CK. 2004. Body weight and abdominal fat gene expression profle in response to a novel hydroxycitric acid-based dietary supplement. Gene Expr 11:251-262. (Pubitemid 38744499)
40. Roy S, Shah H, Rink C, Khanna S, Bagchi D, Bagchi M, Sen CK. 2007. Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. DNA Cell Biol 26:627-639.
41. Sasaki K, Takagi M, Konttinen YT, Sasaki A, Tamaki Y, Ogino T, Santavirta S, Salo J. 2007. Upregulation of matrix metalloproteinase (MMP)-1 and its activator MMP-3 of human osteoblast by uniaxial cyclic stimulation. J Biomed Mater Res B Appl Biomater 80:491-498. (Pubitemid 46245603)
42. Schluter A, Yubero P, Iglesias R, Giralt M, Villarroya F. 2002. The chlorophyll-derived metabolite phytanic acid induces white adipocyte diferentiation. Int J Obes Relat Metab Disord 26:1277-1280.
43. Sergio W. 1988. A natural food, the Malabar Tamarind, may be efective in the treatment of obesity. Med Hypotheses 29:39-40.
44. Shara M, Ohia SE, Schmidt RE, Yasmin T, Zardetto-Smith A, Kincaid A, Bagchi M, Chatterjee A, Bagchi D, Stohs SJ. 2004. Physico-chemical properties of a novel (-)-hydroxycitric acid extract and its efect on body weight, selected organ weights, hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological changes over a period of 90 days. Mol Cell Biochem 260:171-186. (Pubitemid 39127585)
45. Shara M, Ohia SE, Yasmin T, Zardetto-Smith A, Kincaid A, Bagchi M, Chatterjee A, Bagchi D, Stohs SJ. 2003. Dose-and time-dependent efects of a novel (-)-hydroxycitric acid extract on body weight, hepatic and testicular lipid peroxidation, DNA fragmentation and histopathological data over a period of 90 days. Mol Cell Biochem 254:339-346. (Pubitemid 37483770)
46. Shim M, Saab S. 2009. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 54:406-409.
47. Soni MG, Burdock GA, Preuss HG, Stohs SJ, Ohia SE, Bagchi D. 2004. Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt. Food Chem Toxicol 42:1513-1529. (Pubitemid 38844868)
48. Stevens T, Qadri A, Zein NN. 2005. Two patients with acute liver injury associated with the use of the herbal weight-loss supplement Hydroxycut [letter]. Ann Intern Med 142:477-478. (Pubitemid 40365441)
49. Stohs SJ, Press HG, Ohia SE, Kaats GR, Keen CL, Williams LD,Bintock GA. 2010. Safety and efcacy of hydroxycitric acid derived from Garcinia cambogiaA literature review. HerbalGram. 85:58-63.
50. Sullivan AC, Hamilton JG, Miller ON, Wheatley VR. 1972. Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate. Arch Biochem Biophys 150:183-190.
51. Van Guilder GP, Hoetzer GL, Smith DT, Irmiger HM, Greiner JJ, Staufer BL, DeSouza CA. 2005. Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab 289:807-813.
52. Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR, Jr, Siscovick DS, Fornage M. 2007. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis 190:26-34. (Pubitemid 44920229)
53. Westerberg R, Mansson JE, Golozoubova V, Shabalina IG, Backlund EC, Tvrdik P, Retterstol K, Capecchi MR, Jacobsson A. 2006. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J Biol Chem 281:4958-4968. (Pubitemid 43847758)
54. Westerberg R, Tvrdik P, Unden AB, Mansson JE, Norlen L, Jakobsson A, Holleran WH, Elias PM, Asadi A, Flodby P, Toftgard R, Capecchi MR, Jacobsson A. 2004. Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J Biol Chem 279: 5621-5629. (Pubitemid 38220589)
55. Westerterp-Plantenga MS, Kovacs EM. 2002. The efect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int J Obes Relat Metab Disord 26:870-872.